Licensing and Commercialization Agreements (Details) - DelSiTech - License Agreement - EUR (€)		9 Months Ended
	Jun. 30, 2022	Sep. 30, 2022
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Payment period	60 days
Termination notice period	60 days
Avacincaptad Pegol
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Payments for license fees	€ 1,250,000
Avacincaptad Pegol | Achievement of specified clinical and development milestones
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Amount to be paid on achievement of milestone	35,000,000
Avacincaptad Pegol | Achievement of specified commercial sales milestones
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Payments for license fees	€ 60,000,000	€ 60,000,000